Peytant Solutions, Inc. is focused on revolutionizing the treatment of luminal diseases through its innovative use of patented technology. The company specializes in developing stents that are covered with proprietary biomaterials, which are designed to address various conditions that affect the lumens—tubes and chambers within the body, such as those found in the lungs, arteries, and gastrointestinal tract. By leveraging advanced biomaterials, Peytant aims to enhance the effectiveness of stent applications, potentially improving patient outcomes in the management of luminal diseases.

The leadership at Peytant Solutions, Inc. brings extensive experience in the medical device and pharmaceutical industries, with a strong emphasis on interventional and surgical markets. John Schorgl, the co-founder and CEO, has a rich background in executive management and product development, having held significant roles in various reputable companies. His expertise spans multiple sectors, including pulmonary, gastroenterology, and structural heart markets, which positions Peytant to effectively navigate the complexities of biomedical research and translate scientific innovations into practical health solutions.

United States

Peytant Solutions, Inc. (PSI) is a medical device company, incorporating Regenerative Human Biomaterial   with  absorbable and alloy implant technologies. Our percutaneous, biologic AmnioStent...

Peytant Solutions, Inc.

Company Details